Unlearn.AI builds AI-powered digital twins of patients to simulate health outcomes and predict how conditions may evolve. It generates patient-specific virtual replicas from data and runs treatment scenarios to forecast results. Unlike traditional trials, its twins model control groups for clinical studies, potentially reducing the number of real patients needed and speeding drug development. The goal is to speed healthcare decisions, improve trial efficiency, and lower costs by using digital twin simulations to forecast outcomes.
Company Size
51-200
Company Stage
Series C
Total Funding
$130.7M
Headquarters
San Francisco, California
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?